tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Neuren Pharmaceuticals Reports Strong H1 2025 Results and Advances Drug Pipeline
PremiumCompany AnnouncementsNeuren Pharmaceuticals Reports Strong H1 2025 Results and Advances Drug Pipeline
24d ago
Neuren Pharmaceuticals Sees Robust Profit Growth Amid Strategic Buy-Back
Premium
Company Announcements
Neuren Pharmaceuticals Sees Robust Profit Growth Amid Strategic Buy-Back
24d ago
Neuren Pharmaceuticals Initiates Phase 3 Trial for Phelan-McDermid Syndrome
Premium
Company Announcements
Neuren Pharmaceuticals Initiates Phase 3 Trial for Phelan-McDermid Syndrome
26d ago
Neuren Pharmaceuticals to Quote 1.5 Million New Securities on ASX
PremiumCompany AnnouncementsNeuren Pharmaceuticals to Quote 1.5 Million New Securities on ASX
2M ago
Neuren Pharmaceuticals Issues New Equity Securities Under Employee Scheme
Premium
Company Announcements
Neuren Pharmaceuticals Issues New Equity Securities Under Employee Scheme
2M ago
Neuren Pharmaceuticals Announces Quotation of New Securities on ASX
Premium
Company Announcements
Neuren Pharmaceuticals Announces Quotation of New Securities on ASX
3M ago
Neuren Pharmaceuticals Updates on Buy-Back Program
PremiumCompany AnnouncementsNeuren Pharmaceuticals Updates on Buy-Back Program
3M ago
Neuren Pharmaceuticals Updates on Share Buy-Back Program
Premium
Company Announcements
Neuren Pharmaceuticals Updates on Share Buy-Back Program
3M ago
Neuren Pharmaceuticals Updates on Daily Buy-Back Activity
Premium
Company Announcements
Neuren Pharmaceuticals Updates on Daily Buy-Back Activity
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100